Ofatumumab vs Teriflunomide: Phase 3 ASCLEPIOS I/II Open-Label Extension Study

Video

Related Videos
Lisa Mosconi, PhD
Charbel Moussa, MBBS, PhD
Debra Miller
Charbel Moussa, MBBS, PhD
Kelly Papesh, DNP, APRN, FNP-BC
Patricia Clark, CNP
© 2024 MJH Life Sciences

All rights reserved.